NADmed test is ideal for clinical chemistry . It is simple, quick, robust and scalable. Competitive solutions such as mass spectrometry are costly, require expensive specialized equipment and expertise. NADmed allows accessing the full set of NAD metabolites in their oxidized and reduced forms while competitive solutions can analyze only half. Two patents are pending to secure a solid IP position on the NAD testing market.
Comparison of NAD+ levels (µM) in health and disease. NAD+ metabolites were extracted and analysed with the proprietary NADmed in blood of five patients with a specific metabolic disease and compared to six healthy individuals.